Crossmark

Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment

Crossref DOI link: https://doi.org/10.1016/j.nefroe.2024.03.004

Published Print: 2024-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

de la Prada Álvarez, Francisco José

Cintra Cabrera, Melissa

Almenara Tejederas, Marina

Burgos Martin, Javier

Alonso García, Fabiola

Salgueira Lazo, Mercedes
License Information

Text and Data Mining valid from 2024-03-01

Text and Data Mining valid from 2024-03-01

Version of Record valid from 2024-03-16
More Information

This article is maintained by: Elsevier

Article Title: Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment

Journal Title: Nefrología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefroe.2024.03.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nefro.2023.03.003

Content Type: simple-article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología.